Overview Fundamentals API Earnings EOD API Sample Code Pricing

ONCOTHERAPY SCIENCE INC. (30O F) stock market data APIs

€0.177 0.03(20.1%) as of October 29, 2024

Price chart is built with Anychart

OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan. Its development pipeline includes OTS167, a small molecular compound that targets the maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a small molecule TOPK inhibitor currently under non-clinical stage. The company's pipeline also comprises cancer peptide vaccines, including S-588410, which completed Phase III clinical trials for the treatment esophageal cancer, as well as Phase II clinical trials for the treatment of bladder cancer; S-488210, which is in Phase I/II clinical trials for the treatment of head and neck cancer; S-588210, which is in Phase I clinical trials for the treatment of solid tumor; and OTSGC-A24, currently in Phase I clinical trials for the treatment of gastric cancer. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and an anti-amyloid beta peptide antibody that completed Phase I clinical trials for Alzheimer's disease. The company was incorporated in 2001 and is headquartered in Kawasaki, Japan.

ONCOTHERAPY SCIENCE INC. Financial Data Overview

Prev. Close	0.149
Open	0.177
Volume	-
High	0.177
Low	0.149
52 wk Range	0.067-0.364
Market Cap	53 060 K
P/E Ratio
Shares Outstanding	257 M
Revenue	562 M
EPS
Dividends (Yield)
Beta	0.423

Our easy-to-use no-coding solutions help you get the data effortlessly:

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Prices start at $19.99/month

General: {

Code: '30O',

Type: 'Common Stock',

Name: 'ONCOTHERAPY SCIENCE INC.',

Exchange: 'F',

CurrencyCode: 'EUR',

CurrencyName: 'Euro',

CurrencySymbol: '€',

CountryName: 'Germany',

CountryISO: 'DE',

OpenFigi: NULL,

ISIN: 'JP3202150003',

CIK: NULL,

EmployerIdNumber: NULL,

FiscalYearEnd: 'March',

IPODate: NULL,

InternationalDomestic: NULL,

Sector: 'Healthcare',

Industry: 'Biotechnology',

}

ONCOTHERAPY SCIENCE INC. Fundamental Data is available in our Financial Data APIs

Net Revenue 562 M
EBITDA -1 091 000 064
Earnings Per Share -0.04
Income Statements
Balance Sheets
Cash flows

Fundamental data package from $59.99 See full price

Get sample
of Fundamental API Data

Get ONCOTHERAPY SCIENCE INC. Earnings via APIs

Latest Release NaN
EPS/Forecast NaN

Calendar package from $19.99 See full price

Get sample
earnings calendar API

Get ONCOTHERAPY SCIENCE INC. End-of-day Data via APIs

End of Day, Intraday and Live APIs
Splits
Dividends

All world package from $19.99 See full price

Get sample
of End-of-Day API Data

Robust, powerful and easy to use

Our advantages

Prices start at
$19.99

Fast+ support 24/7 via web-chat and email

Robust, powerful and reliable data

One click API for all financial data you need

Sample code for your quick start

Ready-to-go solutions

Our easy-to-use no-coding solutions help you get the data directly to MS Excel and Google Sheets. Or download the CSV (TXT) files effortlessly with tools for Windows and Linux.

Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

Best price for all data API

Prices start at $19.99/month

All-In-One

$99.99/per month

100 000+ API requests per day
EOD Data - All World Extended
Splits and Dividends
Fundamental Data
Bonds Data
Options Data
1000+ currency pairs
1000+ cryptocurrency pairs

Do you have any questions?

support@eodhistoricaldata.com